Edition:
United Kingdom

Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Capital Market

2.93USD
19 Jan 2018
Change (% chg)

$0.16 (+5.78%)
Prev Close
$2.77
Open
$2.80
Day's High
$3.03
Day's Low
$2.78
Volume
442,851
Avg. Vol
347,808
52-wk High
$4.24
52-wk Low
$0.50

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 4.61 -0.224
Jun '17 0.35 -0.301
Mar '17 2.53 -0.116
FY 2016 Dec '16 0.13 -0.074
Sep '16 0.99 -0.065
Jun '16 0.19 -0.129
Mar '16 1.20 -0.133
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 1 1.88 1.88 1.88 4.17
Quarter Ending Jun-18 1 3.79 3.79 3.79 5.09
Year Ending Dec-18 3 11.79 12.17 11.30 8.42
Earnings (per share)
Quarter Ending Mar-18 2 -0.06 -0.06 -0.06 -0.10
Quarter Ending Jun-18 2 -0.05 -0.05 -0.06 -0.10
Year Ending Dec-18 3 -0.36 -0.21 -0.60 -0.38
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 85.70 32.90
P/E High - Last 5 Yrs. -- 302.09 46.03
P/E Low - Last 5 Yrs. -- 94.18 24.39
Beta 1.22 0.88 0.89
Price to Sales (TTM) 113.52 94.43 5.45
Price to Book (MRQ) -- 13.36 5.38
Price to Tangible Book (MRQ) -- 13.64 6.89
Price to Cash Flow (TTM) -- 72.87 23.43
% Owned Institutions 55.19 11.52 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.27 1.51
Dividend 5 Year Growth Rate -- 1.72 5.23
Payout Ratio(TTM) -- 16.22 43.58

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 81.87 401.22 9.01
Sales (TTM) vs TTM 1 Yr. Ago -80.14 71.05 5.44
Sales - 5 Yr. Growth Rate -56.68 33.10 10.34
EPS (MRQ) vs Qtr. 1 Yr. Ago -134.12 29.49 19.33
EPS (TTM) vs TTM 1 Yr. Ago -136.08 -- --
EPS - 5 Yr. Growth Rate -- 40.21 10.77
Capital Spending - 5 Yr. Growth Rate -69.44 40.33 15.26

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.77 2.18
Current Ratio (MRQ) 2.82 5.23 2.97
LT Debt to Equity (MRQ) -- 21.05 12.10
Total Debt to Equity (MRQ) -- 22.61 16.38
Interest Coverage (TTM) -4.32 -102.06 33.13

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 41.21 54.76
Gross Margin - 5 Yr. Avg. -- 52.54 52.45
EBITD Margin (TTM) -788.96 -- --
EBITD - 5 Yr. Avg -429.91 -239.51 15.33
Operating Margin (TTM) -789.53 -519.41 7.60
Operating Margin - 5 Yr. Avg. -510.96 -256.70 10.79
Pre-Tax Margin (TTM) -1,315.52 -494.96 8.38
Pre-Tax Margin - 5 Yr. Avg. -524.47 -256.63 11.19
Net Profit Margin (TTM) -1,316.79 -496.46 4.70
Net Profit Margin - 5 Yr. Avg. -524.64 -259.85 7.50
Effective Tax Rate (TTM) -- 23.29 23.05
Effective Tax Rate - 5 Yr. Avg. -- 18.77 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 200,100 23,318,311 855,725,045
Net Income/Employee (TTM) -2,634,900 3,079,098 100,665,187
Receivable Turnover (TTM) 4.58 20.24 5.76
Inventory Turnover (TTM) -- 2.31 3.34
Asset Turnover (TTM) 0.09 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -123.74 0.09 10.97
Return on Assets - 5 Yr. Avg. -50.47 0.51 12.39
Return on Investment (TTM) -166.61 3.19 14.40
Return on Investment - 5 Yr. Avg. -65.79 3.64 16.20
Return on Equity (TTM) -- 4.52 16.09
Return on Equity - 5 Yr. Avg. -93.64 8.98 17.53
  1 Year 3 Year 5 Year
Sales % -86.78 24.83 -56.68
EPS (TTM) % -44.13 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aveo Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 52.37%
# of Holders: 66
Total Shares Held: 61,954,386
3 Mo. Net Change: 46,698
# New Positions: 3
# Closed Positions: 1
# Increased Positions: 3
# Reduced Positions: 1
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.